Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Stämm Biotech

start up
United States - San Francisco, California
  • 01/03/2022
  • Series A
  • $17,000,000

Stämm is a biotechnology company dedicated to making biomanufacturing easy, scalable, and repeatable. We have developed the first methodology for continuous industrial production of biologics and cell therapies leveraging microfluidics and 3D printing.

In 2020, the total volume of anthropogenic mass matched the total amount of biomass globally, which means it matched everything that is alive on the planet. We can only expect that this number keeps increasing since it's key to solving humanity's systemic challenges.
But we have to make sure that conquering the great challenges of humanity doesn’t extinguish the planet’s capacity to sustain life.

The current way of biomanufacturing has provided humanity with innumerable solutions. Bioprocessing is the most efficient way to align human advancement with a thriving nature. In order to prevent nature from perishing, we aim to put it at the center of all human activities by incorporating its knowledge system within the process of achieving humanity's prosperity.

Founded in 2016, Stämm mimics nature’s use of laminar flow to down-size a whole biotech facility into an all-in-one, plug & play desktop unit. Our focus is to decentralize bioprocesses and democratize access to biotechnology products, thus freeing our partners to focus on the disruptive discoveries that make an impact on people’s life.


Related People

Yuyo Llamazares VeghFounder

Yuyo Llamazares Vegh Argentina - ND

I am a multifaceted Biotech Innovator with a proven track record of successfully developing cutting-edge technology solutions for organizations in the biotechnology industry. Throughout my career, I have upheld a mission to bring the Industrial Revolution 4.0 to the Biotech Industry by developing a bioengineering company that incorporates leading technology solutions to develop advanced equipment for the biotech industry. As a dedicated scientist, I studied Agriculture Engineering at the University of Buenos Aires, I have gained expertise in various disciplines, including microbiology, synthetic biology, phytopathology, separation methods, nanotechnology, and microfluidics through research, projects, publications, and studies. I am recognized in my field as a resourceful and analytical thinker who solves issues in interdisciplinary environments through the development of new technologies using an exponential approach with potential for global impact.